Ultragenyx Pharmaceutical
RARE
#3266
Rank
A$5.30 B
Marketcap
$56.44
Share price
1.44%
Change (1 day)
-16.64%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$15.42

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$16.10. In 2022 the company made an earnings per share (EPS) of -$15.89 a decrease over its 2021 EPS that were of -$10.55.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$15.42-2.99%
2022-$15.8950.67%
2021-$10.55113.69%
2020-$4.94-55.9%
2019-$11.1982.56%
2018-$6.13-45.15%
2017-$11.1814.68%
2016-$9.7557.36%
2015-$6.1969.83%
2014-$3.6515.22%
2013-$3.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.22-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.43-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.07-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA